Related references
Note: Only part of the references are listed.Landscape of genomic alterations in cervical carcinomas
Akinyemi I. Ojesina et al.
NATURE (2014)
Improved Survival with Bevacizumab in Advanced Cervical Cancer
Krishnansu S. Tewari et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Oncogenic Mutations in Cervical Cancer Genomic Differences Between Adenocarcinomas and Squamous Cell Carcinomas of the Cervix
Alexi A. Wright et al.
CANCER (2013)
Radiochemotherapy plus 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in advanced-stage cervical and vaginal cancers
Charles A. Kunos et al.
GYNECOLOGIC ONCOLOGY (2013)
Chemotherapy for advanced and recurrent cervical carcinoma: Results from cooperative group trials
Charles A. Leath et al.
GYNECOLOGIC ONCOLOGY (2013)
Inhibition of Poly(ADP-Ribose) Polymerase Enhances Radiochemosensitivity in Cancers Proficient in DNA Double-Strand Break Repair
Lauren Shunkwiler et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
HER2 Expression Beyond Breast Cancer: Therapeutic Implications for Gynecologic Malignancies
Diana P. English et al.
MOLECULAR DIAGNOSIS & THERAPY (2013)
Efficacy in high burden locally advanced cervical cancer with concurrent gemcitabine and cisplatin chernoradiotherapy plus adjuvant gemcitabine and cisplatin: Prognostic and predictive factors and the impact of disease stage on outcomes from a prospective randomized phase III trial
A. Duenas-Gonzalez et al.
GYNECOLOGIC ONCOLOGY (2012)
A phase I trial of tailored radiation therapy with concomitant cetuximab and cisplatin in the treatment of patients with cervical cancer: A gynecologic oncology group study
Kathleen N. Moore et al.
GYNECOLOGIC ONCOLOGY (2012)
Immune responses against human papillomavirus (HPV) infection and evasion of host defense in cervical cancer
Toshiyuki Sasagawa et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Phase II study of cisplatin plus cetuximab in advanced, recurrent, and previously treated cancers of the cervix and evaluation of epidermal growth factor receptor immunohistochemical expression: A Gynecologic Oncology Group study
John Farley et al.
GYNECOLOGIC ONCOLOGY (2011)
Phase III, Open-Label, Randomized Study Comparing Concurrent Gemcitabine Plus Cisplatin and Radiation Followed by Adjuvant Gemcitabine and Cisplatin Versus Concurrent Cisplatin and Radiation in Patients With Stage IIB to IVA Carcinoma of the Cervix
Alfonso Duenas-Gonzalez et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
A Phase III Trial of Paclitaxel plus Carboplatin Versus Paclitaxel plus Cisplatin in Stage IVB, Persistent or Recurrent Cervical Cancer: Gynecologic Cancer Study Group/Japan Clinical Oncology Group Study (JCOG0505)
Isamu Saito et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Host immune responses to cervical cancer
Swati Patel et al.
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2009)
A phase I study of gemcitabine followed by cisplatin concurrent with whole pelvic radiation therapy in locally advanced cervical cancer: A Gynecologic Oncology Group study
Peter G. Rose et al.
GYNECOLOGIC ONCOLOGY (2007)
Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: A gynecologic oncology group study
Peter G. Rose et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Immunotherapy for gynaecological malignancies
G Coukos et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2005)
Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix
R Pearcey et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix
WA Peters et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
